Mov Disord Vol 33, Suppl 2 Archives - Page 51 of 177 - MDS Abstracts

2018 International Congress
Apolipoprotein E and multiple system atrophy
K. Ogaki, Y. Martens, M. Heckman, S. Koga, L. Labbé, O. Lorenzo-Betancor, A. Wernick, R. Walton, A. Soto, E. Vargas, H. Nielsen, S. Fujioka, T. Kanekiyo, R. Uitti, J. van Gerpen, W. Cheshire, Z. Wszolek, P. Low, W. Singer, N. Hattori, D. Dickson, G. Bu, O. Ross (Tokyo, Japan)
Objective: This study evaluated genetic associations of Apolipoprotein E alleles with risk of multiple system atrophy (MSA) and α-synuclein pathology, and also examined whether apolipoprotein…
2018 International Congress
[18F]FP-CIT and [18F]FDG PET findings in MSA patients with cognitive impairment
KB. Lee, YJ. Park, C. Lee (Seoul, Republic of Korea)
Objective: We investigated the brain dopaminergic system and glucose metabolism in multiple system atrophy (MSA) patients with cognitive impairment. Background: Since the first report of…
2018 International Congress
Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)
A. Shoeibi, I. Litvan, J. Juncos, Y. Bordelon, D. Riley, S. Reich, D. Shprecher, D. Hall, C. Marras, B. Kluger, N. Olfati, J. Jankovic (Mashhad, Islamic Republic of Iran)
Objective: To evaluate the accuracy of the IPD-MDS-PSP criteria to differentiate PSP-Richardson (PSP-R) from PSP-parkinsonism (PSP-P), the most common PSP phenotypes. Background: The new International…
2018 International Congress
Patient Perspective in Multiple System Atrophy
A. Mahajan, Z. Mari (Detroit, MI, USA)
Objective: To report patient and/ or caregiver perspective in Multiple System Atrophy (MSA). Background: The majority of literature on MSA’s natural history comes from single…
2018 International Congress
Peripheral immune activation was associated with multiple system atrophy
B. Cao, XP. Chen, WH. Feng, QQ. Wei, LY. Zhang, HF. Shang (Chengdu, China)
Objective: Our aim is to clarify the correlations between peripheral immune activation and the prevalence as well as the disease severity of MSA. Background: Alpha-synuclein…
2018 International Congress
Clinical indicators of advanced Parkinson’s disease: Evaluating diagnostic properties from retrospective analysis of multi-country, cross-sectional observational study
P. Odin, Z. Pirtosek, R. Rodriguez, P. Martinez-Martin, D. Shah, P. Kandukuri, O. Koray, J. Zamudio, Y. Bao, Y. Jalundhwala, A. Antonini (Lund, Sweden)
Objective: To measure the diagnostic properties of clinical indicators of advanced Parkinson Disease (APD). Background: Lack of consensus to define APD may lead to delay…
2018 International Congress
Psychosocial Impact of dysarthria: Is speech intelligibility an effective measure outcome?
C. Atkinson-Clement, A. Letanneux, M. Berthelot, D. Robert, C. Robieux, C. Moreau, G. Baille, A. Eusebio, F. Fluchère, E. Robin, T. Witjas, J.P. Azulay (Aix-en-Provence, France)
Objective: To identify if intelligibility or social repercussions of dysarthria determined quality of life in patients with different kinds of movement disorders. Background: Dysarthria in…
2018 International Congress
Quality of Life and Psychiatric Comorbidities Comparisons in Patients with Functional (Psychogenic) and Organic Movement Disorders
T. Gendre, G. Carle, F. Mesrati, M. Houot, B. Degos, B. Garcin (Créteil, France)
Objective: To compare the quality of life (QoL) and psychiatric comorbidities of patients with functional (psychogenic) movement disorders (FMD) and patients with organic movements disorders…
2018 International Congress
Predictors of health-related quality of life in Parkinson’s disease
G. Kuhlman, M. Barrett, J. Flanigan (Charlottesville, VA, USA)
Objective: To determine predictors of health-related quality of life (HRQoL) in patients with Parkinson’s disease (PD). Background: Determining the disease characteristics and symptoms associated with…
2018 International Congress
The change of SIRT1 and HIF-1 in MPTP treated mouse
X.X. Cui, S.Y. Dong, Y.J. Guo, W.J. Zhao, Y.C. Wu (Shanghai, China)
Objective: To study the changes of the expression of silent information adjustment factor 1 (SIRT1) and hypoxia inducing factor 1 (HIF-1) and changes in behavior…